The Chemours Company (CC) is a Chemicals - Specialty company in the Basic Materials sector, currently trading at $22.89. It has a SharesGrow Score of 30/100, indicating a weak investment profile with 0 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of CC = $190.17 (+730.8% from the current price, the stock appears undervalued). Analyst consensus target is CC = $19 (-17.6% upside).
Valuation: CC trades at a trailing Price-to-Earnings (P/E) of -8.6 (S&P 500 average ~25).
Financials: revenue is $5.8B, -5%/yr average growth. Net income is $386M (loss), growing at -184.6%/yr. Net profit margin is -6.6% (negative). Gross margin is 15.5% (-8.3 pp trend).
Balance sheet: total debt is $4.6B against $250M equity (Debt-to-Equity (D/E) ratio 18.34, leveraged). Current ratio is 1.78 (strong liquidity). Debt-to-assets is 62.1%. Total assets: $7.4B.
Analyst outlook: 9 / 20 analysts rate CC as buy (45%) — mixed sentiment.
SharesGrow 7-Criteria breakdown: Value 56/100 (Partial), Growth 15/100 (Fail), Past 50/100 (Partial), Health 33/100 (Fail), Moat 31/100 (Fail), Future 16/100 (Fail), Income 10/100 (Fail).
